Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).
Nigel Gaymond joined the BioIndustry Association (BIA) in January 2010 as Chief Executive.
Prior to joining the BIA , Nigel Gaymond provided consultancy services to a range of life sciences companies in the USA and Europe through his consulting practice, Gaymond International, focusing on the life sciences biotechnology, medical device/technology, pharmaceutical, veterinary health, and Ag/bio. He has also worked as a Managing Partner at the healthcare and technology development company Mosaigen and as Director of Corporate Development for the corporate transaction adviser Tranziger.
Previously, Nigel Gaymond served for nearly seven years as a Commercial Officer at the British Consulate-General in Boston, Massachusetts, where he ran the Commercial Department in assisting the UK's biotechnology, healthcare and agriculture exports and became the British government's lead Commercial Officer for biotechnology in the US. He was also the founding CEO of the Edinburgh BioAlliance in Scotland, has been a special adviser to the Invest in Sweden Agency in North America; operated BELS (British Expats in Life Sciences), a network that linked the hundreds of ex-patriate "Brits" working in the life sciences in North America; and published SN(i)PS, a subscription weekly life sciences news digest.
Before moving to the US in 1985 for his role at the British Consulate-General, Nigel Gaymond spent some time in sales and marketing at IBM in the UK, having started his working life as a teacher.
Currently, Nigel Gaymond is on the Board of Trustees of The Forsyth Institute in the US, the leading independent dental and craniofacial research organization in the world, where he is involved in various business development activities. Nigel Gaymond also chairs the US Business Advisory Board of the Child Health Research Institute doing business as CureKids, and was a member of the North American board of the New Zealand Beachheads program, chairing its Life Science panel of advisors, and having now moved over to the UK Board of this programme. Previously he served on the boards of the Scottish BioNetwork Association, the British American Business Council of New England and the New England Chapter of the British Olympic Association.
Nigel Gaymond is a former first class rugby player in the UK who played on two national championship teams and also was a semi-professional jazz musician in his younger days.
Nigel Gaymond has a BSc in Linguistic and International Studies from the University of Surrey, and a post-graduate degree in Education.